BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

Beijing Prime Gene Therapeutics Co., Ltd. is an innovative pharmaceutical company based in China and facing the world. Based on filling unmet clinical needs, the company focuses on new drug discovery, R&D and commercialization featuring immune/inflammatory diseases and external use, and is committed to becoming a leading international pharmaceutical company.

Sixfold Bioscience Ltd. manufactures drugs for cancer treatments. The company was founded by George William Foot, Zuzanna Aleksandra Brzosko and Anna Perdrix Rosell on October 8, 2018 and is headquartered in London, the United Kingdom.

KBSI conducts research support and joint research using advanced research facilities and equipment.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

Yuan Longping High-tech Agriculture is research, produces, and markets seeds, hybrid rice, pepper, corn, cotton, and vegetables. The business offers agricultural services such as brand agriculture, agricultural finance, peasant training, grain trading platforms, cultivated land rehabilitation and development, and precision planting technologies. Peasants, dealers, and other agricultural production methods are all incorporated into the integrated service ecological circle by the corporation to build an agricultural integrated service platform.

Institute of Microelectronics of the Chinese Academy of Sciences was established in 1958 as the CAS No. 109 Semiconductor Factory under the former CAS Institute of Applied Physics. Institute of Microelectronics of the Chinese Academy of Sciences original goal was to meet nation's strategic need to develop a high-frequency transistor computer.

Nicoya Lifesciences, Inc. provides medical services. It develops sensor products to get affinity, kinetics, and specificity for proteins, antibodies, DNA, RNA, enzymes, polymers, and small molecules. The firm offers OpenSPR, OpenSPR-XT, OpenSPR reagents, sensors and accessories products. The company was founded by Shawn Fitzpatrick, John A. G. Dick and Ryan Denomme in 2012 and is headquartered in Kitchener, Canada.

Ancera is focused on engineering simple, practical, rapid, and cost-effective diagnostics products that can cause a revolutionary change to the quality of service provided to the end-user. The company's PIPER platform, enables near real-time, rapid detection and quantification of microbial threats across all points in the food production process, from farm-to-consumer. Their flagship product is a rapid, labor- and label-free cell sorter and immunoassay. It is capable of cell sorting, concentration, manipulation, and detection of clinically significant samples (>1cc) in <10 minutes. Their device has high sensitivity and specificity and does not require any sample preparation, handling, or incubation. Ancera offers an integrated solution capable of label-free sorting, microscopy, enumeration, assaying, and recovery of cells directly from complex food sources. They monitor and assess microbial data to provide meaningful operational and food security outcomes for the food industry.

Sirna Therapeutics, Inc. was a San Francisco, California based biotechnology company that explored the use of RNA interference in human disease therapy. Sirna's development pipeline includes several small interfering RNA (siRNA) drugs, thought to stably silence the expression of specific disease-related genes. Sirna's clinical trial of an siRNA-based treatment for age-related macular degeneration is the first such trial for an siRNA drug.

Wankangyuan (Tianjin) Gene Technology Co., Ltd., established on 2015-01-06, The business scope includes genetic medicine related equipment and electronic products,Technology development of computer hardware and software,transfer,Consulting and Services;Health Information Consultation(Except for medical advice);biotechnology development,Technical Services,technology transfer,technical consulting;Conference Services;Exhibition;Computer System Services;Computer hardware and software and auxiliary equipment,Equipment,Instrumentation,Chemical Products(Hazardous chemicals and precursor drugs are excluded),Wujinjiaodian,Machinery sales;Goods and technology import and export business;Pharmaceutical Technology Development,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Kangbaiyu Biotechnology Co., Ltd., established on 2016-11-09, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:Biotechnology,biological reagent,medical technology,medical technology,cell therapy technology,cell antibody(antibody drug),immune booster,medical instruments,Scientific Instruments and Reagents,computer network Technology,Computer hardware and software;technology development,technical consulting:genetic testing technology,Gene diagnosis and diagnosis and treatment technology,gene medicine,stem cell,Extraction of immune cells and genes,amplify,detection,storage(Non-cord blood sources);online sale:cosmetic(Repacking),hygiene products,electronic product,Mechanical equipment and spare parts,Instrumentation,Chemical raw materials and products(Removal of hazardous chemicals and precursor chemicals),laboratory equipment,Computer hardware and software;Sales(Including online sales):medical instruments(Limited to one category,Class II),biological reagent,Biological Consumables;Serve:Business Management Consulting;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Nippon Telegraph & Telephone Corp. operates as a holding company which engages in the provision of telecommunication services. It operates through the following business divisions: Regional Communications, Long-Distance and International Communications, Mobile Communications, Data Communications, and Others. The Regional Communications division offers domestic intra-prefectural communication services such as fixed voice-related, Internet protocol (IP), and packet communications services; and sells telecommunications equipment. The Long Distance and International Communications division deals with the domestic intra-prefectural and international communications, and system integration services. The Mobile Communications division provides the mobile voice-related, IP, and packet communications services. The Data Communications division covers the system integration and network system services. The Other division engages in the real estate, finance, engineering, system integration and data processing services, and development of technologies and shared operations. The company was founded on August 1, 1952 and is headquartered in Tokyo, Japan.

Part of Microsoft Corp., Microsoft Technology Licensing LLC is a company headquartered in Tumwater, WA. The firm offers patent, licensing and legal support services for Microsoft products.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.